Cosmederm Gains CFDA Approval for Topical Skin Treatment
8/12/2013 2:57:22 PM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
August 12, 2013 -- Cosmederm Bioscience of San Diego, Hong Kong and Shenzhen, received CFDA approval for TriCalm® Anti-Itch Hydrogel, an OTC topical treatment for itching, burning or stinging skin conditions. In April 2013, the company’s Tricalm Eczema Creme was approved for marketing by the CFDA, its first China approval. More details....
Help employers find you! Check out all the jobs and post your resume.
comments powered by